These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33517002)

  • 21. Synthesis and biological activities of artemisinin-piperazine-dithiocarbamate derivatives.
    Yu JY; Li XQ; Wei MX
    Eur J Med Chem; 2019 May; 169():21-28. PubMed ID: 30852384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Sulfonamide Derivatives Carrying a Biologically Active 3,4-Dimethoxyphenyl Moiety as VEGFR-2 Inhibitors.
    Ghorab MM; Alsaid MS; Nissan YM; Ashour AE; Al-Mishari AA; Kumar A; Ahmed SF
    Chem Pharm Bull (Tokyo); 2016; 64(12):1747-1754. PubMed ID: 27904083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Parthenolide Dimers as Activators of Pyruvate Kinase M2 in Xenografts of Glioblastoma Multiforme in Vivo.
    Ding Y; Xue Q; Liu S; Hu K; Wang D; Wang T; Li Y; Guo H; Hao X; Ge W; Zhang Y; Li A; Li J; Chen Y; Zhang Q
    J Med Chem; 2020 Feb; 63(4):1597-1611. PubMed ID: 31977207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, in vitro anticancer evaluation, kinase inhibitory effects, and pharmacokinetic profile of new 1,3,4-triarylpyrazole derivatives possessing terminal sulfonamide moiety.
    Abdel-Maksoud MS; El-Gamal MI; Gamal El-Din MM; Oh CH
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):97-109. PubMed ID: 30362383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment.
    Zhou Y; Huang Z; Su J; Li J; Zhao S; Wu L; Zhang J; He Y; Zhang G; Tao J; Zhou J; Chen X; Peng C
    Int J Cancer; 2020 Jul; 147(1):139-151. PubMed ID: 31652354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents.
    Mantipally M; Gangireddy MR; Gundla R; Badavath VN; Mandha SR; Maddipati VC
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2248-2253. PubMed ID: 31239178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis.
    Gao P; Shen S; Li X; Liu D; Meng Y; Liu Y; Zhu Y; Zhang J; Luo P; Gu L
    Drug Des Devel Ther; 2020; 14():2091-2100. PubMed ID: 32546972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro effects of some flavonoids and phenolic acids on human pyruvate kinase isoenzyme M2.
    Aslan E; Guler C; Adem S
    J Enzyme Inhib Med Chem; 2016; 31(2):314-7. PubMed ID: 25798688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy.
    Shamsi F; Hasan P; Queen A; Hussain A; Khan P; Zeya B; King HM; Rana S; Garrison J; Alajmi MF; Rizvi MMA; Zahid M; Imtaiyaz Hassan M; Abid M
    Bioorg Chem; 2020 May; 98():103754. PubMed ID: 32200329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents.
    Hao S; Cheng X; Wang X; An R; Xu H; Guo M; Li C; Wang Y; Hou Z; Guo C
    Bioorg Chem; 2020 Nov; 104():104237. PubMed ID: 32911194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and biological evaluation of novel sesquiterpene lactone derivatives as PKM2 activators with potent anti-ulcerative colitis activities.
    Ma L; Li M; Lv J; Yuan Q; Yin X; Lu W; Lin W; Wang P; Cui J; Lv Q; Liu J; Hu L
    Eur J Med Chem; 2024 Jun; 272():116426. PubMed ID: 38718622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PKM2 inhibitor shikonin suppresses TPA-induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells.
    Li W; Liu J; Zhao Y
    Mol Carcinog; 2014 May; 53(5):403-12. PubMed ID: 23255458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and structure-guided fragment-linking of 4-(2,3-dichlorobenzoyl)-1-methyl-pyrrole-2-carboxamide as a pyruvate kinase M2 activator.
    Matsui Y; Yasumatsu I; Asahi T; Kitamura T; Kanai K; Ubukata O; Hayasaka H; Takaishi S; Hanzawa H; Katakura S
    Bioorg Med Chem; 2017 Jul; 25(13):3540-3546. PubMed ID: 28511909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of novel sulfonamide-containing aminophosphonate derivatives as selective COX-2 inhibitors and anti-tumor candidates.
    Zhang B; Hu XT; Gu J; Yang YS; Duan YT; Zhu HL
    Bioorg Chem; 2020 Dec; 105():104390. PubMed ID: 33137555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
    Bakr RB; Mehany ABM; Abdellatif KRA
    Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin K(3) and K(5) are inhibitors of tumor pyruvate kinase M2.
    Chen J; Jiang Z; Wang B; Wang Y; Hu X
    Cancer Lett; 2012 Mar; 316(2):204-10. PubMed ID: 22154083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting pyruvate kinase muscle isoform 2 (PKM2) in cancer: What do we know so far?
    Chhipa AS; Patel S
    Life Sci; 2021 Sep; 280():119694. PubMed ID: 34102192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
    Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
    Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel bis(pyrazole-benzofuran) hybrids possessing piperazine linker: Synthesis of potent bacterial biofilm and MurB inhibitors.
    Mekky AEM; Sanad SMH
    Bioorg Chem; 2020 Sep; 102():104094. PubMed ID: 32711085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.